Features of illnesses caused by five species of Campylobacter, Foodborne Diseases Active Surveillance Network (FoodNet) - 2010-2015

M E Patrick, O L Henao, T Robinson, A L Geissler, A Cronquist, S Hanna, S Hurd, F Medalla, J Pruckler, B E Mahon, M E Patrick, O L Henao, T Robinson, A L Geissler, A Cronquist, S Hanna, S Hurd, F Medalla, J Pruckler, B E Mahon

Abstract

The Foodborne Diseases Active Surveillance Network (FoodNet) conducts population-based surveillance for Campylobacter infection. For 2010 through 2015, we compared patients with Campylobacter jejuni with patients with infections caused by other Campylobacter species. Campylobacter coli patients were more often >40 years of age (OR = 1·4), Asian (OR = 2·3), or Black (OR = 1·7), and more likely to live in an urban area (OR = 1·2), report international travel (OR = 1·5), and have infection in autumn or winter (OR = 1·2). Campylobacter upsaliensis patients were more likely female (OR = 1·6), Hispanic (OR = 1·6), have a blood isolate (OR = 2·8), and have an infection in autumn or winter (OR = 1·7). Campylobacter lari patients were more likely to be >40 years of age (OR = 2·9) and have an infection in autumn or winter (OR = 1·7). Campylobacter fetus patients were more likely male (OR = 3·1), hospitalized (OR = 3·5), and have a blood isolate (OR = 44·1). International travel was associated with antimicrobial-resistant C. jejuni (OR = 12·5) and C. coli (OR = 12) infections. Species-level data are useful in understanding epidemiology, sources, and resistance of infections.

Keywords: Campylobacter; food-borne infections; surveillance.

Conflict of interest statement

None.

Figures

Fig. 1.
Fig. 1.
Distribution of patients with Campylobacter infection, by age group and species – FoodNet, 2010–2015.
Fig. 2.
Fig. 2.
Distribution of Campylobacter species by geographic region – FoodNet, 2010–2015.
Fig. 3.
Fig. 3.
Campylobacter infections by species, location, and age group – FoodNet, 2010–2015.
Fig. 4.
Fig. 4.
Seasonal distribution of patients with Campylobacter infection by species, overall and by international travel history – FoodNet, 2010–2015.

References

    1. Scallan E, et al. Foodborne illness acquired in the United States – major pathogens. Emerging Infectious Diseases 2011; 17(1): 7–15.
    1. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. (). Accessed 29 August 2014.
    1. Fitzgerald C. Campylobacter. Clinics in Laboratory Medicine 2015; 35(2): 289–298.
    1. FDA. NARMS Integrated Report: 2012–2013. The National Antimicrobial Resistance Monitoring System: Enteric Bacteria (). Accessed 19 November 2015.
    1. Wagenaar JA, et al. Campylobacter fetus infections in humans: exposure and disease. Clinical Infectious Diseases 2014; 58(11): 1579–1586. doi: 10.1093/cid/ciu085. Epub 2014 Feb 18.
    1. Gilbert MJ, et al. Occurrence, diversity, and host association of intestinal Campylobacter, Arcobacter, and Helicobacter in reptiles. PLoS ONE 2014; 9(7): e101599. doi: 10.1371/journal.pone.0101599. eCollection 2014.
    1. Acke E, et al. Prevalence of thermophilic Campylobacter species in household cats and dogs in Ireland. Veterinary Record 2009; 164(2): 44–47.
    1. Matsuda M, Moore JE. The epidemiology and zoonotic transmission of thermophilic Campylobacter lari. British Microbiology Research Journal 2011; 1(4): 104–121.
    1. Taylor EV, et al. Common source outbreaks of Campylobacter infection in the USA, 1997–2008. Epidemiology and Infection 2013; 141(5): 987–996. doi: 10.1017/S0950268812001744. Epub 2012 Aug 15.
    1. Gillespie IA, et al. A case-case comparison of Campylobacter coli and Campylobacter jejuni infection: a tool for generating hypotheses. Emerging Infectious Diseases 2002; 8: 937–942.
    1. Bessède E, et al. Comparison of characteristics of patients infected by Campylobacter jejuni, Campylobacter coli, and Campylobacter fetus. Journal of Clinical Microbiology. 2014; 52(1): 328–330. doi: 10.1128/JCM.03029-13. Epub 2013 Nov 6.
    1. Linton D, et al. PCR detection, identification to species level, and fingerprinting of Campylobacter jejuni and Campylobacter coli direct from diarrheic samples. Journal of Clinical Microbiology 1997; 35: 2568–2572.
    1. CDC. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): Human Isolates Final Report, 2013. Atlanta, Georgia: U.S. Department of Health and Human Services, CDC, 2015.
    1. United States Department of Agriculture Economic Research Service ().
    1. Green CG, Krause DO, Wylie JL. Spatial analysis of Campylobacter infection in the Canadian province of Manitoba. International Journal of Health Geographics 2006; 5: 2.
    1. Ethelberg S, et al. Spatial distribution and registry-based case-control analysis of Campylobacter infections in Denmark, 1991–2001. American Journal of Epidemiology 2005; 162(10): 1008–1015. Epub 2005 Oct 5.
    1. Nylen G, et al. The seasonal distribution of Campylobacter infection in nine European countries and New Zealand. Epidemiology and Infection 2002; 128(3): 383–390.
    1. Doorduyn Y, et al. Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in The Netherlands: a case-control study. Epidemiology and Infection 2010; 138(10): 1391–1404. doi: 10.1017/S095026881000052X. Epub 2010 Mar 12.
    1. Friedman CR, et al. Risk factors for sporadic Campylobacter infection in the United States: a case-control study in FoodNet sites. Clinical Infectious Diseases 2004; 38(Suppl. 3): S285–S296.
    1. Boysen L, Vigre H, Rosenquist H. Seasonal influence on the prevalence of thermotolerant Campylobacter in retail broiler meat in Denmark. Food Microbiology 2011; 28(5): 1028–1032. doi: 10.1016/j.fm.2011.02.010.
    1. Willis WL, Murray C. Campylobacter jejuni seasonal recovery observations of retail market broilers. Poultry Science 1997; 76(2): 314–317.
    1. Schonberg-Norio D, et al. Swimming and Campylobacter infections. Emerging Infectious Diseases 2004; 10: 1474–1477.
    1. Roux F, et al. Elucidating the aetiology of human Campylobacter coli infections. PLoS ONE 2013; 8(5): e64504. doi: 10.1371/journal.pone.0064504. Print 2013.
    1. Neal KR, et al. Omeprazole as a risk factor for Campylobacter gastroenteritis: case-control study. British Medical Journal 1996; 312: 414–415.
    1. Sopwith W, et al. Investigation of food and environmental exposures relating to the epidemiology of Campylobacter coli in humans in Northwest England. Applied and Environmental Microbiology 2010; 76(1): 129–135. doi: 10.1128/AEM.00942-09. Epub 2009 Oct 23.
    1. Zeigler M, et al. Outbreak of campylobacteriosis associated with a long-distance obstacle adventure race – Nevada, October 2012. MMWR Morbidity and Mortality Weekly Report 2014; 63(17): 375–378.
    1. Bessell PR, et al. Using sequence data to identify alternative routes and risk of infection: a case-study of Campylobacter in Scotland. BMC Infectious Diseases 2012; 12: 80. doi: 10.1186/1471-2334-12-80.
    1. Trokhymchuk A, et al. Prevalence and diversity of Campylobacter species in Saskatchewan retail ground beef. Journal of Food Protection 2014; 77(12): 2106–2110. doi: 10.4315/0362-028X.JFP-14-247.
    1. Gazaigne L, et al. Campylobacter fetus bloodstream infection: risk factors and clinical features. European Journal of Clinical Microbiology and Infectious Diseases 2008; 27(3): 185–189. Epub 2007 Nov 13.
    1. Broczyk A, et al. Water-borne outbreak of Campylobacter laridis-associated gastroenteritis. Lancet 1987; 1(8525): 164–165. PMID:2880002.
    1. Van Hees BC, et al. Regional and seasonal differences in incidence and antibiotic resistance of Campylobacter from a nationwide surveillance study in The Netherlands: an overview of 2000–2004. Clinical Microbiology and Infection 2007; 13(3): 305–310.
    1. Kassenborg HD, et al. Fluoroquinolone-resistant Campylobacter infections: eating poultry outside of the home and foreign travel are risk factors. Clinical Infectious Diseases 2004; 38(Suppl. 3): S279–S284.
    1. Pollett S, et al. Campylobacter antimicrobial resistance in Peru: a ten-year observational study. BMC Infectious Diseases 2012; 12: 193–200.
    1. Post A, et al. Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between 2007 and 2014. European Jounal of Clinical Microbiology and Infectious Diseases 2017. doi: 10.1007/s10096-017-3032-6. [Epub ahead of print].
    1. Steffen R, Hill DR, DuPont HL. Traveler's diarrhea: a clinical review. Journal of the American Medical Association 2015; 313(1): 71–80. doi: 10.1001/jama.2014.17006. Review.
    1. Allos BM, Blaser M. Campylobacter jejuni and related species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th edn. Churchill, Livingstone: Elsevier Press, Philadelphia, PA, 2010, p. 2799.
    1. Council of State and Territorial Epidemiologists. Standardized Surveillance for Campylobacteriosis and Addition to the Nationally Notifiable Condition List. Atlanta, GA: Council of State and Territorial Epidemiologists, 2003. (). Accessed 15 June 2015.
    1. CSTE. State legal requirements for submission of isolates and other clinical materials by clinical laboratories: a review of state approaches () Accessed 15 May 2017.
    1. Hurd S, et al. Clinical laboratory practices for the isolation and identification of Campylobacter in Foodborne Diseases Active Surveillance Network (FoodNet) sites: baseline information for understanding changes in surveillance data. Clinical Infectious Diseases 2012; 54(Suppl. 5): S440–S445. doi: 10.1093/cid/cis245.
    1. Mandrell RE, et al. Speciation of Campylobacter coli, C. jejuni, C. helveticus, C. lari, C. sputorum, and C. upsaliensis by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Applied and Environmental Microbiology 2005; 71(10): 6292–6307.
    1. Iwamoto M, et al. Bacterial enteric infections detected by culture-independent diagnostic tests – FoodNet, United States, 2012–2014. MMWR Morbidity and Mortality Weekly Report 2015; 64(9): 252–257.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner